Thoracic Tumor - Somatic and germinal, both are deletions by Dr. Lucio Ghiglione
Cáncer de torax
Learning from failures by Dr. Helena Oliveres
Selecting patients for PARPis in Ovarian Cancer: ¿How can we best indentify them? by Dr. Lydia Gaba
Cáncer de ovario
Intrinsic Subtypes and Therapeutic Decision-Making in HR+HER2-negative Metastatic Breast Cancer by Dr. Francesco Schettini
DNA repair and clinical evolutiol of metastatic prostate cancer by Dr. Caterina Aversa
Cáncer de mama
Change in phenotype and somatic BRCA1 mutation in a patient with advanced breast cancer by Dr. Barbara Adamo
Cáncer de mama
Done right, went wrong by Dr. Victor Albarran
Can be guided treatment strategy without somatic molecular profile? by Dr. Juan Carlos Laguna
Precision medicine in non-melanoma skin cancer by Dr. Elia Segui
Cáncer de piel
Unexpected response in a rare tumor by Dr. David Pesantez
Cáncer raro
Mejorando la supervivencia en cáncer de mama mestatásico by Dr. Maria Vidal
Cáncer de mama metastásico
Beyond BRCA1 and 2 in ovarian cancer by Dr. Adela Rodríguez
Cáncer de Ovario
"Not everything is what it seems to be”... The correct interpretation of tumor molecular studies and the importance of a multidisciplinar approach Dr. Belen Pastor
Cáncer hereditario
Never too late to think twice by Dr. Marta García de Herreros
Diagnóstico y abordaje de una neoplasia
Do we have predictive biomarkers in urothelial carcinoma (UC) beyond FGFR alterations? by Dr. Oscar Reig
Agnostic Biomarker in solid tumors by Dr. Laura Angelats
Cáncer genitourinario
What acral melanoma hides by Dr. Roberto Martín
Cáncer de piel
Molecular Family by Dr. Roxana Reyes
Biología molecular
Is there any rol for precision medicine in rare pacreatic cancer? by Dr. Francis Espósito
Cáncer Gástrico
Beyond the classical EGFR resistance mechanisms by Teresa Gorria
The protein EGFR
Breast cancer: Beyond intrinsic subtypes by Raquel Gómez
Cáncer de mama
Intrahepatic cholangiocarcinoma: beyond chemotherapy by Dr. Iván Victoria
Exploiting genomics in serous endometrial cancer by Lydia Gaba
Cáncer ginecológico
Beyond classical BRAF mutations in melanoma by Dr. Marta García de Herreros
Cáncer de piel
Can we talk about Precision Immuno-Oncology in HR+ HER2- Breast Cancer? by Elia Seguí